Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PRDM1 Antikörper (AA 501-600)

Dieser Anti-PRDM1 Antikörper ist ein Kaninchen Polyklonal Antikörper zur Detektion von PRDM1 in WB, ELISA, IHC (p), IF (cc), IF (p) und IHC (fro). Geeignet für Maus.
Produktnummer ABIN1387860

Kurzübersicht für PRDM1 Antikörper (AA 501-600) (ABIN1387860)

Target

Alle PRDM1 Antikörper anzeigen
PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))

Reaktivität

  • 57
  • 15
  • 11
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Maus

Wirt

  • 34
  • 22
  • 3
  • 2
Kaninchen

Klonalität

  • 38
  • 23
Polyklonal

Konjugat

  • 45
  • 6
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser PRDM1 Antikörper ist unkonjugiert

Applikation

  • 50
  • 27
  • 13
  • 9
  • 8
  • 7
  • 5
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
  • Bindungsspezifität

    • 7
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 501-600

    Kreuzreaktivität

    Maus

    Homologie

    Human,Rat,Cow,Pig,Horse,Chicken,Rabbit

    Aufreinigung

    Purified by Protein A.

    Immunogen

    KLH conjugated synthetic peptide derived from human PRDM1/Blimp1

    Isotyp

    IgG
  • Applikationshinweise

    WB 1:300-5000
    ELISA 1:500-1000
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 μg/μL

    Buffer

    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

    Haltbarkeit

    12 months
  • Target

    PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))

    Andere Bezeichnung

    PRDM1

    Hintergrund

    Synonyms: Blimp 1, Blimp-1, B Lymphocyte Induced Maturation Protein 1, Beta interferon gene positive regulatory domain I binding factor, Beta-interferon gene positive regulatory domain I-binding factor, BLIMP-1, BLIMP1, Positive Regulatory Domain I Binding Factor 1, Positive regulatory domain I-binding factor 1, PR Domain Containing 1, PR domain containing 1 with ZNF domain, PR domain containing 1 with ZNF domain isoform 2, PR domain containing protein 1, PR domain zinc finger protein 1, PR domain-containing protein 1, PRDI BF1, PRDI binding factor 1, PRDI-BF1, PRDI-binding factor 1, PRDM 1, Prdm1, PRDM1_HUMAN.

    Background: The development and differentiation of plasma cells, which are terminally differentiated B-cells, are induced by Blimp-1 (B lymphocyte-induced maturation protein, also designated PRDI-BF1). Blimp-1 is a transcriptional repressor that localizes to the nucleus and is considered a master regulator of terminal B-cell development. Alone, Blimp-1 is sufficient to trigger terminal B-cell differentiation. Blimp-1 upregulates the expression of syndecan-1 and J chain, represses IFN-b gene transcription and associates with HDAC to recruit it to DNA, thereby repressing c-myc. Blimp-1 is expressed during the late stages of B-cell differentiation in immunoglobulin-secreting plasma cells, as well as in long-lived, bone marrow plasma cells. The expression of Blimp-1 defines a checkpoint beyond which fully activated B cells proceed to the plasma cell stage, whereas immature and partially activated cells are eliminated.

    Gen-ID

    144423

    Pathways

    Regulation of Muscle Cell Differentiation
Sie sind hier:
Chat with us!